We chatted LIVE with:
Generating 8.1 million impressions.
With 128 communicators.
And almost 900 tweets.
Sets out 23 forward-looking commitments in the report to help measure future performance
Submitted by: GlaxoSmithKline PLC
Posted: Mar 20, 2013 – 10:36 AM EST
LONDON, Mar. 20 /CSRwire/ - GSK has today published its Corporate Responsibility Report, in which it reiterates its commitment to operate responsibly, openly and transparently and outlines advances made on this agenda during 2012. In the report, the company also sets out 23 forward-looking commitments aligned with its core areas of strategic focus including access to medicines, transparency and environmental sustainability. Corporate responsibility is central to GSK’s strategy to deliver sustainable financial performance whilst providing shared value to patients, consumers and governments.
GSK CEO Sir Andrew Witty said: “Operating in a trustworthy and responsible way underpins our business success. Our record in 2012 shows we are making good progress – taking significant steps to increase clinical data transparency, leading the Access to Medicines Index and doubling funding for our independent research into diseases of the developing world at our Open Lab at Tres Cantos, Spain. We recognise there is more we can do and we will continue to challenge ourselves to find new approaches to create value for both society and shareholders and to improve lives around the world. That is why we are setting out new long-term commitments which will allow those outside the company to track our progress and hold us to account more effectively.”
Setting these new commitments will enable the company to more effectively measure and communicate the progress it makes on this agenda. The report includes commitments to:
Click here for the full list of commitments in the 2012 Corporate Responsibility report. GSK will begin reporting progress against these new commitments in its next report.
GlaxoSmithKline (NYSE: GSK) – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
For more information, please contact: